Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Saiyed Atiq Raza sold 19,809 shares of the stock in a transaction that occurred on Friday, June 27th. The shares were sold at an average price of $10.02, for a total transaction of $198,486.18. Following the completion of the transaction, the director directly owned 683,798 shares of the company's stock, valued at $6,851,655.96. The trade was a 2.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Arteris Stock Up 0.8%
Shares of Arteris stock traded up $0.07 on Wednesday, reaching $9.09. 435,795 shares of the stock were exchanged, compared to its average volume of 227,578. The business has a 50 day moving average price of $7.85 and a two-hundred day moving average price of $8.58. The firm has a market capitalization of $381.60 million, a price-to-earnings ratio of -11.09 and a beta of 1.44. Arteris, Inc. has a twelve month low of $5.46 and a twelve month high of $12.64.
Wall Street Analyst Weigh In
Separately, Rosenblatt Securities reissued a "buy" rating and issued a $14.00 target price on shares of Arteris in a research report on Wednesday, May 21st.
View Our Latest Report on AIP
Institutional Trading of Arteris
Institutional investors and hedge funds have recently bought and sold shares of the business. Quarry LP purchased a new stake in shares of Arteris in the fourth quarter worth about $46,000. US Bancorp DE lifted its holdings in Arteris by 29.0% in the fourth quarter. US Bancorp DE now owns 5,702 shares of the company's stock valued at $58,000 after acquiring an additional 1,283 shares during the period. CWM LLC lifted its holdings in Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after acquiring an additional 10,005 shares during the period. Cambridge Investment Research Advisors Inc. purchased a new stake in Arteris in the 1st quarter worth approximately $95,000. Finally, Strs Ohio acquired a new stake in shares of Arteris during the 1st quarter worth approximately $104,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.
Arteris Company Profile
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.